Infliximab shows superior drug survival among biologics for hidradenitis suppurativa: A cohort study

Authors

Albert T. Young, Henry Ford HealthFollow
Kathy Lu, Henry Ford HealthFollow
Andrea Dai, Henry Ford HealthFollow
Iltefat Hamzavi, Henry Ford HealthFollow
Richard H. Huggins, Henry Ford HealthFollow
Indra Adrianto, Henry Ford HealthFollow
Li Zhou, Henry Ford HealthFollow
Qing-Sheng Mi, Henry Ford HealthFollow

Recommended Citation

Young AT, Lu K, Dai A, Hamzavi I, Huggins RH, Adrianto I, Zhou L, and Mi QS. Infliximab shows superior drug survival among biologics for hidradenitis suppurativa: a cohort study. J Am Acad Dermatol 2024.

Document Type

Article

Publication Date

9-17-2024

Publication Title

Journal of the American Academy of Dermatology

PubMed ID

39299517

ePublication

ePub ahead of print